1999
DOI: 10.1006/jmcc.1999.0981
|View full text |Cite
|
Sign up to set email alerts
|

Reduced Myocardial Sarcoplasmic Reticulum Ca2+-ATPase Protein Expression in Compensated Primary and Secondary Human Cardiac Hypertrophy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0

Year Published

2000
2000
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(12 citation statements)
references
References 53 publications
0
12
0
Order By: Relevance
“…Also, isotransient is due to a dysfunction of the sarcoplasmic prenaline-activated, and maximal catalytic capacity of the reticulum probably caused by changes in the expression of AC was unaltered in AF patients. These data provide direct 21 Ca handling proteins [18,23,24]. Also, an upregulation evidence that the b-adrenergic signal transduction pathway…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…Also, isotransient is due to a dysfunction of the sarcoplasmic prenaline-activated, and maximal catalytic capacity of the reticulum probably caused by changes in the expression of AC was unaltered in AF patients. These data provide direct 21 Ca handling proteins [18,23,24]. Also, an upregulation evidence that the b-adrenergic signal transduction pathway…”
Section: Discussionmentioning
confidence: 94%
“…Results homogenate aliquots was carried out using polyacrylamide 21 gels [18]. After tank blotting the nitrocellulose (0.45 mm) 3.1.…”
Section: Adenylyl Cyclase Activity 21 Patientsmentioning
confidence: 99%
“…21,22 In addition, several studies of myocardial samples from HCM patients after myectomy have suggested that functional abnormalities in Ca 2ϩ -handling proteins, including SERCA2, might be involved in abnormal intracellular Ca 2ϩ handling and thus, in impaired contractile performance in HCM patients. [23][24][25] SERCA2 is clearly recognized as a major determinant of myocardial contractility. 26 In a recent study in genetically engineered mice models, Kadambi et al 22 implicated the ratio of SERCA2 to phospholamban as a contributing factor in determining the frequency response of cardiac muscle.…”
Section: Discussionmentioning
confidence: 99%
“…The present study mainly concerned p16-PLB, since it is considered to be the major regulator of PLB activity during ␤-adrenergic stimulation (10). Under pathological conditions, several studies have reported decreased expression of SERCA 2a, the predominant isoform in the heart (43), in failing human myocardium (2,34) and in animal models of pressure overload-induced hypertrophy, especially in SHR (3). This abnormality of SERCA 2a would lead to abnormalities in Ca 2ϩ handling, especially significant alteration of [Ca 2ϩ ] i (4,5), which appears to be involved in hypertrophic cell growth (28).…”
mentioning
confidence: 99%